Related Experiment Video
Updated: Dec 5, 2025

26:48
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
18.6K
Anti-Ma encephalitis masquerading as Wernicke encephalopathy
Huanyu Meng1, Qinming Zhou1, Sheng Chen1
1Ruijin Hospital, Department of Neurology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Summary
Anti-Ma encephalitis, a rare autoimmune disorder, can mimic Wernicke encephalopathy. Early suspicion is crucial, especially when Vitamin B1 treatment fails in patients with neurological symptoms and potential cancer.
Area of Science:
- Neurology
- Oncology
- Immunology
Background:
- Anti-Ma encephalitis is typically linked to testicular cancer in young males.
- Gastric cancer association with Anti-Ma encephalitis presenting as Wernicke encephalopathy-like symptoms is uncommon.
- This report details a rare case in an elderly patient initially misdiagnosed.
Observation:
- A 71-year-old male with alcohol abuse presented with dizziness, diplopia, and anorexia.
- Initial Wernicke encephalopathy diagnosis and Vitamin B1 treatment were ineffective.
- Detection of anti-Ma1/2 antibodies in blood and CSF confirmed the diagnosis.
Findings:
- 18F-FDG PET-MR revealed hypermetabolic changes in the hypothalamus, basal ganglia, and brainstem.
- Gastric neoplasms with liver metastasis were identified.
- The patient was diagnosed with Anti-Ma encephalitis.
Implications:
- Anti-Ma encephalitis should be considered in patients with Wernicke encephalopathy-like symptoms unresponsive to Vitamin B1.
- This case highlights the importance of antibody testing for accurate diagnosis.
- Timely diagnosis and treatment are crucial for managing this rare autoimmune encephalitis.
More Related Videos
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
1.7K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.7K
Anticholinesterase Agents: Poisoning and Treatment
1.4K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.4K

